2021-09-20
World Alzheimer's Day takes place on 21 September and is part of World Alzheimer's Month, raising awareness for this disease and how it impacts the daily lives of people affected by the condition and challenge the stigma that surrounds it.
Read more
2021-09-17
Alzinova will participate at Redeye Investor Forum Online on September 23, 2021 at 15:20 CEST, where CEO Kristina Torfgård… Read more
2021-09-01
World Alzheimer's Month is the international campaign every September to raise awareness for Alzheimer’s disease and how it impacts the daily… Read more
2021-08-27
Captario Analyst, Stephanie Mardini wrote an article on alzheimersdisease and our work to develop a potential vaccine. Check it… Read more
2021-07-07
Alzinova is participating at the AAIC 2021 (Alzheimer’s Association International Conference). Read more
2021-06-30
”We felt it was important to participate in GU Ventures' roundtable discussion at the DI Impact Summit since good health… Read more
2021-06-09
The FDA granted an accelerated approval for aducanumab on June 7, 2021. The decision to approve a new treatment… Read more
2021-06-08
The US Food and Drug Administration (FDA) communicated yesterday its decision to approve the investigational drug, aducanumab, for the… Read more
2021-06-07
In the US, June is Alzheimer's & Brain Awareness month. "The more people know about Alzheimer's, the more action… Read more
2021-06-02
2021-05-17
At Aktiespararna's Aktiedagen on Monday, our CEO, Kristina Torfgård provided an update on Alzinova and progress on the first… Read more
2021-05-05
On May 5 our CEO, Kristina Torfgård, attended the Captario Webinar together with AstraZeneca: From Small to Large in… Read more
2021-04-29
2021-04-16
Researchers are confident that it will soon be possible to do blood tests to see if there are signs… Read more
2021-04-09
Listen to the latest episode of Data, Pharma & Fika with our collaboration partner Captario, where Ingela Nylander our… Read more
2021-03-19
Our CEO, Kristina Torfgård, recently participated in a webcast discussion on Alzheimer's disease together with the CEOs of two… Read more
2021-03-03
Alzinova has recently initiated a collaboration with Captario to further optimize the company's development strategies. Read more
2021-03-01
Alzinova's CEO Kristina Torfgård was interviewed on February 26, 2021 by Redeye’s Life Science analyst Anders Hedlund. Read more
2021-02-25
"2020 was an important year and, our goal-oriented work has ensured that we are well prepared for the start… Read more
2021-02-10
Alzinova is collaborating with prominent researchers at Sahlgrenska University Hospital in Gothenburg, Sweden, to track markers of neurodegenerative change… Read more
2021-01-18
In a Research Note posted last week, equity research and investment banking company, Redeye, commented on “another external validation”… Read more
2020-09-14
World Alzheimer's Day takes place on 21 September and is part of World Alzheimer's Month, raising awareness for this disease… Read more
2020-06-16
Alzinova, a Swedish biopharmaceutical company developing disease-modifying treatments against Alzheimer’s Disease, has moved into AstraZeneca’s BioVentureHub in Gothenburg. Read more
